Ridaura Generic Name & Formulations
Auranofin 3mg; caps.
DMARD (gold salt).
Active rheumatoid arthritis unresponsive to NSAIDs.
Ridaura Dosage and Administration
Initially 6mg daily in 1–2 divided doses. If response inadequate after 6 months, may increase to 3mg 3 times daily. If still ineffective after 3 months, discontinue.
History of gold-induced disorders.
Ridaura Boxed Warnings
Gold toxicity. Physicians should be experienced in chrysotherapy.
Be fully familiar with chrysotherapy and this product's toxicity and benefits before use. Impaired renal or hepatic function. Inflammatory bowel disease. Rash. History of bone marrow depression. Monitor CBC with differential, platelet count, urinalysis, renal, liver function and for GI bleeding. Discontinue immediately if thrombocytopenia, proteinuria, or hematuria occurs. Pregnancy (Cat.C), nursing mothers: not recommended.
Ridaura Adverse Reactions
Bone marrow depression, proteinuria, hematuria, diarrhea, GI upset, ulcerative colitis, rash, pruritus, exfoliative dermatitis, stomatitis, conjunctivitis, proteinuria, nephrotic syndrome, cholestatic jaundice, gold bronchitis, pneumonitis, peripheral neuropathy.
Ridaura Clinical Trials
Ridaura Patient Counseling